Next Article in Journal
Ruminant Salivary Microbes: Passenger or Player in the Rumen?
Next Article in Special Issue
Antimicrobial Resistance of Actinobacillus pleuropneumoniae, Streptococcus suis, and Pasteurella multocida Isolated from Romanian Swine Farms
Previous Article in Journal
Efficacy of Different Encapsulation Techniques on the Viability and Stability of Diverse Phage under Simulated Gastric Conditions
Previous Article in Special Issue
Toxoplasmosis Screening during Pregnancy in a Romanian Infectious Diseases Tertiary Center: Results of a 15 Years Follow-Up Program
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 11
Issue 10
10.3390/microorganisms11102388
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cystic Echinococcosis in Hospitalized Adult Patients from Western Romania: 2007–2022

by
Ana Alexandra Paduraru
1,2,3,4,
Maria Alina Lupu
1,2,3,5,
Laurentiu Sima
6,7,
Gabriel Veniamin Cozma
6,8,
Sorin Dan Olariu
9,10,
Sorin Dan Chiriac
11,
Bogdan Dan Totolici
12,
Catalin Alexandru Pirvu
9,13,
Fulger Lazar
9,14,
Alexandru Nesiu
15,16,
Alin Gabriel Mihu
1,2,15,
Alin Adrian Cumpanas
17,
Octavian Marius Cretu
6,7,* and
Tudor Rares Olariu
1,2,3,4
1
Discipline of Parasitology, Department of Infectious Diseases, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
2
Center for Diagnosis and Study of Parasitic Diseases, Department of Infectious Disease, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
3
Patogen Preventia, 300124 Timisoara, Romania
4
Clinical Laboratory, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania
5
Clinical Laboratory, Institute of Cardiovascular Diseases, 300310 Timisoara, Romania
6
Discipline of Surgical Semiology I and Thoracic Surgery, Department of Surgery I, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
7
General Surgery Clinic, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania
8
Thoracic Surgery Clinic, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania
9
General Surgery Clinic, County Clinical Emergency Hospital, 300254 Timisoara, Romania
10
Discipline of Surgery I, Department of Surgery II, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
11
Discipline of Surgery III, Department of Surgery II, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
12
Department of General Surgery, Vasile Goldis Western University of Medicine and Pharmacy, 310025 Arad, Romania
13
Discipline of Surgical Emergencies, Department of Surgery II, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
14
Discipline of Surgery II, Department of Surgery II, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
15
Department of Biology and Life Sciences, Vasile Goldis Western University of Medicine and Pharmacy, 310025 Arad, Romania
16
Department of Urology, Arad County Emergency Clinical Hospital, 310037 Arad, Romania
17
Discipline of Urology, Department XV, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(10), 2388; https://doi.org/10.3390/microorganisms11102388
Submission received: 23 August 2023 / Revised: 16 September 2023 / Accepted: 19 September 2023 / Published: 25 September 2023
(This article belongs to the Special Issue State-of-the-Art Parasitic and Bacterial Infections in Romania)
Browse Figures
Versions Notes

Abstract

:
Cystic echinococcosis (CE) is a neglected parasitic disease caused by the tapeworm Echinococcus granulosus. The aim of this study was to assess the epidemiological features of human cystic echinococcosis in patients from Western Romania. We retrospectively investigated the medical records of patients hospitalized with CE between 1 January 2007 and 1 September 2022. A total of 366 patients (range 18–90 years) were recorded. The number of hospitalized individuals was higher in patients aged 50–59 years (83/366, 22.7%), in females (194/366, 53%), and in residents of rural areas (225/366, 61.5%). The liver was the most common localization of the cysts (302/366, 82.5%). Ninety-eight patients (26.8%) presented complications, including biliary fistula, allergies, and infection of the cyst. Patients with complications had a longer mean hospital stay (15.7 ± 8.3 days) compared to patients without complications (11.5 ± 7.3 days) (p < 0.001). The results of this study revealed that patients diagnosed with CE required hospitalization and extended medical care, indicating that this zoonotic disease remains a significant public health problem in Western Romania. Public health authorities should enhance CE surveillance by implementing control programs and mandatory notification of new cases.

1. Introduction

Human echinococcosis is a neglected parasitic disease caused by the larval stages of Echinococcus tapeworms. Cystic echinococcosis (CE) is caused by the Echinococcus granulosus tapeworm [1,2,3]. The definitive hosts of E. granulosus are canids, infected through the ingestion of viscera containing viable hydatid cysts. Livestock animals (sheep, cattle, pigs, horses, and goats) are the intermediate hosts of the parasite and harbor the parasitic metacestode [2,3,4]. The interaction between predators and prey is essential to the life cycle of E. granulosus [1]. Humans are considered accidental hosts as they become infected by ingesting the parasitic eggs and are less likely to be involved in further transmission of disease [3,5]. Humans get the infection through consumption of food, water, or soil contaminated with dog feces containing parasitic eggs [6]. Moreover, eggs may remain attached to dogs’ fur when eliminated with feces. Close contact with dogs can lead to accidental ingestion of these eggs [7].
Data from the literature mention that pathogenesis processes linked with Echinococcus infections may be used to analyze the interactions between opposing forces generated by humoral and cellular immunostimulant and immunosuppressive mediators. It was observed that through the inhibitory action of Th2 and T reg immune responses, the host defenses may be avoided, permitting chronic worm infection [8]. Cystic echinococcosis is distinguished by the growth of single or multiple hydatid cysts [9]. Up to 80% of the cases are characterized by the development of solitary cysts in single organs [5]. Hydatid cysts remain asymptomatic for a long time due to their slow growth, and clinical manifestations depend on the organ involved [10,11]. They are usually diagnosed after months or even years [4]. Although any organ can be affected, hydatid cysts are mostly found in the liver (70%) and lungs (20%) [5]. Hepatomegaly, portal hypertension, cholestasis, biliary cirrhosis, ascites, and several other manifestations (upper abdominal pain, abdominal distention, loss of appetite, jaundice) have been reported in patients with hepatic cysts. Cysts rupture in the biliary tree, which may result in cholestasis and cholangitis, or into the peritoneum, resulting in anaphylaxis or secondary CE. Abscess may develop if cysts become infected. Symptoms of pulmonary cysts include chronic cough, expectoration, dyspnea, hemoptysis, pleuritis, and lung abscess [1,4].
Imaging techniques such as ultrasonography, radiology, computerized tomography, or magnetic resonance imaging are important tools in diagnosing cystic echinococcosis. Serology is based on finding the specific antibodies in the serum of a patient, and along with the imaging techniques help in establishing the diagnosis [3,4]. Still, specific anti-Echinococcus antibody production depends on various factors like the individual immune response, the affected organ, or the number of hydatid cysts [12].
Treatment of cystic echinococcosis depends on multiple factors, like localization and/or number of cysts, cystic developmental stage, size, the presence of complications, and patient’s clinical condition [3]. Until recently, surgery was considered the treatment of choice. Nowadays, the minimally invasive puncture-aspiration-injection-re-aspiration (PAIR) procedure, chemotherapy, and the “watch-and-wait” approach are also described as therapeutic options [3,10]. Surgery is efficient in most cases. However, it may not be an option in several circumstances, mainly when a patient has many cysts in various organs, when there is a high surgical risk, or when there are insufficient facilities to perform the intervention [4]. Surgical approaches that do not include total removal of the cyst should be supplemented by the use of protoscolicidal agents [4]. The PAIR technique is a minimally invasive approach that includes: i. percutaneous puncture of the hydatid cyst performed under ultrasound guidance; ii. partial fluid aspiration; iii. inoculation of a protoscoicidal agent; and iv. re-aspiration [13].
Chemotherapy using benzimidazoles is the chosen therapy option for some individuals with inoperable cysts, multiple cysts, or multiple organ involvement [4]. It appears to be more efficient in younger patients than in elderly ones [14]. Albendazole therapy is indicated for the PAIR technique or surgery, one week before and two months following the procedure [1]. The alternative drug for patients with important hepatic side effects is mebendazole [1].
Regardless of the improvements in surgical techniques and the use of chemotherapy, recurrence is still one of the main issues in the treatment of hydatid disease [15]. Recurrence rates in CE vary widely from 0% to 22% and are noticed at intervals of 3 months to 20 years after the initial surgery. Disease recurrence may be associated with severe complications such as intrabiliary rupture, anaphylaxis, and pyogenic infection [15].
Cystic echinococcosis has a worldwide distribution, is found mainly in rural and pastoral areas, and is associated with poor health education and living conditions [3,4]. According to the WHO Foodborne Disease Burden Epidemiology Reference Group (FERG), echinococcosis is responsible for 19 300 deaths and 871 000 disability-adjusted life-years (DALYs) worldwide annually [16]. CE not only causes severe illness and mortality in people, but it also causes economic losses. In humans, CE may have a series of negative effects, including direct financial expenses for diagnosis, hospitalization, surgical or percutaneous treatments, post-treatment care, as well as indirect costs for mortality, pain, loss of working days, social consequences of disability, and abandonment of agricultural activities by affected or at-risk individuals [17]. Livestock losses are due to organ seizures, decreased carcass weight, production of milk, fertility rates, and wool [18,19].
Chile, Uruguay, Argentina, southern Brazil, central Asia, western China, East Africa, and the Mediterranean region are considered endemic areas for cystic echinococcosis [3,5]. The annual incidence in endemic areas can reach 200 per 100,000 people [20]. The high endemicity in these areas is mostly associated with the large number of potential intermediate hosts, animal husbandry, home slaughtering, consumption of unwashed fruits or vegetables, the presence of stray dogs, and low knowledge of the disease [21].
Romania was also included by the World Health Organization [16] on the list of endemic countries [16,22,23]. The endemic occurrence of CE was previously reported in several Romanian regions [24,25]. An epidemiological research conducted between 1985 and 1997 in southwestern Romania revealed that the mean annual CE incidence was 5.1 cases/100,000 with a peak incidence of 9.5 cases/100,000 individuals in 1997 [26,27]. In Cluj County, northwestern Romania, the CE incidence varied between 3.9 and 9.5/100,000 during the period 1991- 2008 [28]. Between 2004 and 2010, a mean annual incidence of 3.3/100,000 was registered in two counties in southwestern Romania (Caras-Severin and Hunedoara) [26]. Of note, in Romania, 45.7% of the population lives in rural area, and approximately 30% of the population is involved in the agricultural sector [29]. According to Eurostat, Romania was in 2021 the second largest sheep breeder in the European Union, after Spain [30].
The aim of this study was to assess the epidemiological features of human cystic echinococcosis in patients hospitalized in surgical clinics in Western Romania for a period of 15 years.

2. Materials and Methods

2.1. Geographical Area of the Study

This study was performed in Arad County and Timis County. Both counties are situated in Western Romania and surrounded by four Romanian counties (Bihor, Alba, Hunedoara, and Caras-Severin) and districts from Hungary and Serbia, respectively [31,32]. These two Romanian counties cover an area of 16,450.7 km2, with a total population of 1,224,186 inhabitants. This geographic region has a temperate continental climate with Mediterranean and oceanic influences (Figure 1) (INS).

2.2. Data Collection

This retrospective study included adult patients aged ≥18 years diagnosed and hospitalized with cystic echinococcosis in Western Romania between 1 January 2007 and 1 September 2022.
All medical records on cystic echinococcosis from three major teaching hospitals (County Emergency Clinical Hospital Arad, Municipal Emergency Clinical Hospital Timisoara, and “Pius Brînzeu” County Emergency Clinical Hospital Timisoara) referral centers for general and thoracic surgery in Western Romania were reviewed.
Data regarding age, gender, area of residence, length of hospital stay, number of hospitalizations due to CE, cyst localization, number of cysts, investigations performed, complications, and treatment were collected and evaluated. Patients were grouped as follows according to their age: 18–29 years, 30–39 years, 40–49 years, 50–59 years, ≥60 years.
According to the medical records, the diagnosis was established based on imaging techniques (ultrasonography, radiology, computerized tomography) and confirmed by anatomopathological examination. Anti-Echinococcus-specific antibody detection using enzyme-linked immunosorbent assays (ELISA) was recorded in only 37/366 (10.1%) of the medical charts.

2.3. Statistical Analyses

All collected data were compiled in a Microsoft 365 Excel database, version 2205 (Microsoft Corp., Redmond, WA). Statistical analyses were performed using the software packages EpiInfo (v. 7.2, CDC, Atlanta, GA, USA, 2018) and MedCalc for Windows (v. 20.015, MedCalc Software, Ostend, Belgium). The chi-squared test, two-tailed Fisher’s exact test, or Mantel–Haenszel test, as appropriate, were used to evaluate associations between the studied groups, while Student’s t-test was used to assess differences between means in the studied groups.
Incidence rates of CE were calculated as the average annual number of cases per 100,000 inhabitants, according to the annual population number provided by the Romanian National Institute of Statistics (INS, 2023). To analyze trends in the number of cases and incidence of the disease over time, a linear regression analysis was performed. A p-value < 0.05 was considered statistically significant.
The study was conducted following the ethical principles of the Declaration of Helsinki and approved by the Ethics Committee of the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania.

3. Results

A total of 366 hospitalized patients were recorded with cystic echinococcosis in Western Romania between 2007 and 2022. Patients included in the study were aged between 18 and 90 years (mean age 46.8 ± 16.2 years), with the age group 50–59 years being more frequently hospitalized (83/366, 22.7%). However, individuals < 50 years old accounted for 202/366 (55.2%) of the cases (Table 1). When comparing the mean ages of females (47.4 ± 16.8 years) and males (46.3 ± 15.7 years), no statistical difference was observed (p = 0.52).
The number of hospitalized cases was apparently higher in females (194/366,53%) and in patients residing in rural areas (225/366,61.5%). However, no significant difference was found between area of residence and gender (p = 0.48), between gender and age groups (p = 0.77), or between area of residence and age groups (p = 0.08) (Table 2).
During the study period, the number of hospitalized cases varied from 10 to 33 cases/year, with an average annual number of 22.9 ± 6.8. The number of hospitalized cases decreased significantly during the studied period, from 29 cases in 2007 to 10 cases in 2022 (R2 = 0.346, p = 0.02) (Figure 2). The decreasing trend was also observed when we assessed the incidence rates of the disease in the adult population (R2 = 0.389, p = 0.009).
The length of hospital stay varied between 1 and 47 days, with a mean of 12.6 ± 7.8 days. A total of 91 (24.8%) of the 366 patients were hospitalized between 1 and 7 days, 158 (43.2%) were hospitalized between 8 and 14 days, and 117 (32%) were hospitalized for more than 14 days. We observed an association between the affected organ and the hospitalization period (ꭕ2 = 31.74, p < 0.001). Thirty of the 48 (62.5%) patients with pulmonary cysts had more than 14 days of hospitalization compared to patients with liver (82/302, 27.2%), kidney (2/4, 50%), or spleen (2/6, 33.3%) cysts, with a similar length of hospital stay.
The liver was the most affected organ (302/366, 82.5%), followed by the lungs (48/366, 13.1%), spleen (6/366, 1.6%), kidneys (4/366, 1.1%), and other anatomical sites, including the retroperitoneum, peritoneum, muscle, and bone, in 6/366 (1.6%) of the cases. In CE with primary liver involvement, the right lobe was affected in 219/302 (72.5%) cases, the left lobe in 57/302 (18.9%), and both lobes in 26/302 (8.6%) cases. In primary lung involvement, the left lung was affected in 24/48 (50%) patients, the right lung in 21/48 (43.8%), and both lungs in 3/48 (6.2%). We observed a significant statistical association between gender and the affected organ (ꭕ2 = 12.8, p = 0.01). Of the patients with liver cysts, females accounted for 171/302 (56.6%) of the cases, while of those with lung and kidney involvement, hydatic cysts were more frequently reported in males, in 29/48 (60.4%) and 4/4 (100%), respectively.
Multiple organ involvement was noted in 23/366 (6.3%) patients. The most frequent associations were liver-lung and liver-peritoneum in 6/23 (26.1%) of the cases, respectively. A triple association of liver-lung-spleen and liver-kidney-spleen was noticed in 1/23 (4.3%) cases, respectively (Table 3).
Complications were reported in 98/366 (26.8%) cases. The main reported complications were biliary fistula (45/98, 45.9%), allergies (15/98, 15.3%), and cyst infection (11/98, 11.2%). There was a statistically significant association between the presence of complications and the length of hospital stay (ꭕ2 = 24.16, p < 0.001). Fifty of the 98 (51%) patients with complications had over 14 days of hospitalization, while only 67/268 (25%) patients without complications had over 14 days of hospitalization (p < 0.001). Moreover, patients with complications had a longer mean hospital stay (15.7 ± 8.3 days) compared to patients without complications (11.5 ± 7.3 days) (p < 0.001).
In all cases, the diagnosis of CE was based on imaging techniques such as ultrasonography, radiography, and computerized tomography and confirmed by demonstrating the presence of protoscoleces in post-surgery samples. Twenty-eight of the 37 (75.7%) serologically tested patients had anti- Echinococcus antibodies.
Surgery was the treatment of choice in 298/366 (81.4%) cases. The PAIR technique was chosen in 53 (14.5%) cases, Albendazole therapy alone was used in 8 (2.2%) cases, and in 7 (1.9%) cases, the ”Watch-and-Wait” approach was preferred (Table 4). Chemotherapy with Albendazole as adjuvant therapy was used in 99/366 (27%) cases (Table 4). In patients with liver cysts, Lagrot partial pericystectomy was performed in 180/302 (59.6%), total cystectomy in 42/302 (13.9%), PAIR technique in 53/302 (17.5%), segmentectomy in 12/302 (4%), oral therapy in 8/302 (2.6%), and the “Watch-and-Wait” approach in 7/302 (2.3%). In patients with lung involvement, cystectomy was performed in 40/48 (83.4%) cases, partial pericystectomy in 4/48 (8.3%), and segmentectomy in 4/48 (8.3%). In spleen involvement, 4 (66.7%) of 6 patients underwent splenectomy and 2/6 (33.3%) underwent partial pericystectomy.
A total of 83 of the 366 (22.7%) patients experienced recurrences. A total of 63 of the 83 (75.9%) patients had two hospitalizations, while the remaining patients (24.1%) had more than two hospital admissions. In patients who received Albendazole therapy, recurrence was identified in 30/366 (8.2%) cases. However, no statistically significant difference was observed between patients who were administered drug therapy compared to those who did not receive any Albendazole therapy regarding the presence of recurrences (p = 0.12).

4. Discussion

According to the World Health Organization, human cystic echinococcosis is one of the most important neglected zoonoses and represents a serious socio-economic problem in many parts of the world [2]. Important morbidity and mortality due to CE were reported, especially in developing countries [33]. Human echinococcosis was reported in most European countries except Denmark, Iceland, and Ireland [34]. The highest rates in Europe were registered in the Mediterranean region [34]. High rates were also reported in Bulgaria, where the average annual incidence reached up to 6.7/100,000 inhabitants [34,35]. Recently, in Eastern European countries, a lower incidence of CE has been reported. For instance, in Eastern Hungary, Dezsényi and colleagues [3] found an incidence of 1.49 cases/100,000 inhabitants, while in Serbia, another country with CE-endemic regions, the incidence was estimated at 0.73/100,000 [12].
Romania is considered one of the endemic countries for cystic echinococcosis, with an incidence rate that reached 5.6 cases/100,000 inhabitants [27]. In Romania, the transmission of CE was associated with various variables like a temperate climate, a high percentage of people working in the agricultural sector, unsupervised home slaughtering of livestock (particularly sheep and pigs), the presence of a significant number of feral dogs, or the absence of antiparasitic treatment in dogs. [23,36,37,38].
In Romania, CE was reported in animals such as sheep, swine, and cattle. In a study performed between 1998 and 2003, field data obtained from Timis District slaughterhouses revealed prevalences of 22.36% in cattle, 5.83% in sheep, and 4.32% in swine [39]. Between 2009 and 2011, in northeastern and southern Romania, Mitrea and colleagues [23] reported prevalences of 49.87% and 32.34% in sheep and cattle, respectively. In a recent study performed between 2020 and 2021, Darabus and colleagues found a CE prevalence of 2.45% in cattle [40]. This reduction in prevalence may indicate an improvement in Romania’s sanitary-veterinary control efforts at the farm level. In addition, advances in canine population control programs (e.g., microchipping of dogs) have increased the possibility for veterinarians to instruct owners to deworm their dogs [40]. Noteworthy, the occurrence of human CE in a geographical region has been linked to the level of sheep-raising activities, especially the density of sheep in the region; this has also been linked to the rates of human CE-related hospital admissions [41].
Hospital-admitted CE cases are recorded in the medical databases, but the precise rate of infection is unknown since many people avoid seeking medical attention due to financial reasons. As a result, many cases are likely to go undiagnosed and unreported, increasing morbidity and death due to CE [42]. In Romania, there are no official national programs for the control of E. granulosus, and there is no obligation to report the new cases. Therefore, hospital discharge records are the only data source available for detecting CE cases in humans. Ultrasound-based screening programs may provide a more precise picture of the epidemiology of CE at the population level. Such investigations permit the identification of ongoing transmission of the parasite and can offer accurate illness prevalence estimations [41,43].
In this study, more than half of the hospitalized patients were aged <50 years. Interesting, about 20% of the patients aged 18–29 years, indicating that subjects in this age group acquired the infection early in childhood. Similarly, in Argentina and Pakistan, CE cases were more commonly reported in young adults (15–29 years in Argentina, 21–30 years in Pakistan) [2,42,44]. A higher susceptibility to CE at young ages might be associated with early exposure to the parasite from contact with dogs, playing in contaminated soil, or involvement in animal grazing [42,44]. Assessment of hospitalized cases according to age groups revealed that almost half of the patients with CE in our study were over 50 years old. An explanation may be that the disease develops over a long period of time, implying a lag between infection and diagnosis [45]. However, the absence of an evident trend in the distribution of CE between the different age groups suggests that CE can manifest at any age [26,42,46,47].
The results of the present study showed a decreasing trend in the number of cases and also in the incidence of the disease between 2007 and 2022. This could be partially attributed to higher awareness of illness in the local community and among healthcare professionals [48]. Another explanation for the decreasing trend could be the implementation of stronger standards concerning safety, food, and health since the accession of Romania to the European Union (EU) in 2007 [49]. Former investigators reported similar results to our findings. Petropoulos and colleagues [50] identified a downward trend in the number of cases during a 39-year period of time in Greece, while Mustapayeva and colleagues [48] observed a decreasing trendline in the incidence of surgical CE cases in Kazakhstan between 2007 and 2016. However, it is important to mention that the significant decrease in cases between 2020 and 2022 in our study might be impacted by the COVID-19 pandemic when hospital admissions were limited.
Regarding the gender distribution of CE, more than half of our patients were female. Similar results were also reported by other authors [12,42,44,51,52,53]. Moreover, in the cross-sectional study on healthy blood donors from Western Romania, females tended to have a higher seropositivity rate compared to males [54]. The high exposure to the parasite in females may be explained by domestic activities such as feeding and close contact with dogs, cleaning dog feces, or contact with contaminated soil [42,44].
Our findings are in concordance with most studies regarding the prevalence of the infection in rural areas. Studies conducted in Palestine, Iran, or Serbia have shown a higher rate of infection in people residing in rural areas [52,53,55]. The distribution of cystic echinococcosis is usually associated with rural areas. Poor rural communities are susceptible to infection due to little knowledge of the disease [34,56]. Farming, especially raising sheep, and home slaughtering are considered important risk factors in developing CE [34,56]. Moreover, a crucial role in the maintenance of the Echinococcus life cycle is played by dogs with little veterinary attention found next to the livestock [51,56]. The E. granulosus life cycle in stray dogs and sheep is maintained by home slaughtering of animals, feeding uncooked viscera to stray dogs near abattoirs, lack of abattoir disposal pits, and low public knowledge on the disease. All these factors contribute to potential environmental contamination [42].
Most of the patients in our study group were hospitalized between 8 and 14 days, and the mean length of hospital stay was 12.6 ± 7.8 days. However, it is important to note that almost a third of the patients had a hospital stay longer than 14 days. In Italy, during 2001–2012, 41% of the patients with CE were hospitalized for 1–7 days, and the mean length of hospitalization was 12.1 ± 12.1 [57]. In Turkey, Akkucuk and colleagues [58] identified a shorter mean length of hospitalization (5.42 ± 3.16 days) in patients with liver hydatid disease.
In the present study, single-organ involvement was observed in the vast majority of the patients. Brundu and colleagues [57] reported similar results, with 88.6% of the cases having cysts in a single organ. Our data indicate that cystic lesions occurred most frequently in the liver (302/366, 82.5%), especially the right lobe (219/302, 72.5%). This outcome was similar to previous findings documented by other authors [59,60]. Frequent hepatic localization might be attributed to the fact that Echinococcus oncospheres must pass first via the liver capillaries and usually remain trapped in the tissue and develop into cysts [56]. Moreover, the right hepatic lobe may be more affected due to portal blood flow [61]. Regarding lung localization, in our study group, hydatic cysts in the lungs were noted in 13% of 366 cases. Previous studies have shown that the right lung may be affected in most cases of pulmonary CE [62]. Interestingly, in our study group, the left lung was the most frequently reported localization compared to the right lung.
The diagnosis of CE is usually based on imaging techniques. Serology may help in supporting the diagnosis, or it may be an indicator of recurrence or relapse [63]. It is known that serology has lower sensitivity than imaging techniques [64]. However, serological studies are performed worldwide to assess the prevalence of infection or to help establish the diagnosis [65,66]. Antibody production mostly depends on the organ affected, the number of cysts, and the presence of complications [63,67]. Serological surveys showed that 10–20% of patients with hepatic involvement and approximately 40% with pulmonary involvement do not develop detectable specific antibodies [4]. In this study, anti-Echinococcus antibodies were positive in 75% of the tested patients. Similar results were reported in Hungary, where anti-Echinococcus antibodies were detected in 17 of the 27 (62.96%) tested patients [3], and in Spain, where 48 of the 93 (51.6%) investigated patients were seropositive [68].
Our findings revealed that more than a quarter of the patients had complications. Recently, in a study conducted in Spain, the reported complication rate was 27/151 (34.6%) [68]. Usually, cysts are diagnosed by incidental radiological or clinical examination [69]. The classification of complications according to their pathogenesis is: mechanical, caused by compression or rupture of the cyst; immunological, caused by allergic reactions to the cyst; and superinfection due to the presence of microorganisms [70]. Intrabiliary rupture of the cyst was found to be the most frequent complication of CE, accounting for incidence rates between 3 and 17% [69]. Rupture usually occurs in the right hepatic duct. Communication often occurs through small fissures; therefore, it is difficult to tell the exact location of the fissure [69]. Bacterial infection is usually a rare complication due to the pericyst avascularity and the lack of communication between the host vascular system and the endocyst. A key requirement for bacterial infection is the rupture of the endocyst and pericyst [69]. Escolà-Vergé and colleagues [68] reported cyst infection as the most common complication in patients hospitalized for CE in Spain. In our study, biliary fistula was the most frequent complication, being described in 45/98 (45.9%) of the patients.
The clinical data recorded in the present study indicate that in Western Romania, surgery was the main option in the management of CE cases. Surgery, using various techniques, has the capacity to remove the cysts, resulting in a full recovery [4]. Albendazole was used in 107 (29.2%) of the 366 patients: main therapy in 8 (2.2%) and adjuvant therapy in 99 (27%). Albendazole is usually used to decrease the risk of relapse, especially in patients undergoing invasive surgical treatment [15,57]. However, 83 (22.7%) of the patients in our study reported having recurrences. Brundu and colleagues [57] also identified high rates of recurrences in a retrospective study conducted in Italy, with 24% of the patients having two hospital stays and 5% having three or more hospitalizations. Lower rates of relapse were reported by Amado-Diago and colleagues [71] and Velasco-Tirado and colleagues [15] in Spain, who identified recurrences in 10.5% and 11.5% cases, respectively. In addition to the low use of Albendazole post-surgery, another important cause for recurrences may be the spillage of hydatid cyst fluid in the abdominal cavity during surgery [72].
Some limitations of this study should be considered. First, there is the retrospective nature of the study. Our results are supported by the available data collected from patients’ medical records. Information regarding other epidemiological aspects that could be potential risk factors for the infection was not included in all the charts. Second, the database included only hospitalized cases. Therefore, the number of our patients does not reflect the total number of CE cases in the two counties, which is probably higher, as a series of cases remain asymptomatic and might go undiagnosed [54].

5. Conclusions

The current retrospective study brings new and important data regarding the epidemiology of CE in Western Romania. Patients diagnosed with CE required hospitalization and extended medical care, indicating that this zoonotic disease remains a significant public health problem in this region.
In reference hospitals, multidisciplinary teams should form to improve the diagnosis and management of CE cases. The implementation of a surveillance system with mandatory notification of new cases should help in monitoring the trends of the disease and improve the patients’ follow-up. Further epidemiological investigation of CE-confirmed cases with a focus on molecular particularities is highly recommended to better understand the transmission patterns of the parasite in Romania.
Furthermore, effective communication between human doctors and veterinarians is essential to improving knowledge on the disease and its prevention measures, especially among at-risk populations. Public health strategies for human and animal infection should be optimized, including control programs and increasing awareness regarding the transmission of the parasite.

Author Contributions

Conceptualization, A.A.P., O.M.C. and T.R.O.; methodology, A.A.P., O.M.C. and T.R.O.; formal analysis, A.A.P., M.A.L., L.S., G.V.C., S.D.O., S.D.C., B.D.T., C.A.P., F.L., A.N., A.G.M., A.A.C., O.M.C. and T.R.O.; investigation, A.A.P., M.A.L., L.S., G.V.C., S.D.O., S.D.C., B.D.T., C.A.P., F.L., A.N., A.G.M., A.A.C., O.M.C. and T.R.O.; resources, A.A.P., M.A.L., L.S., G.V.C., S.D.O., S.D.C., B.D.T., C.A.P., F.L., A.N., A.G.M., A.A.C., O.M.C. and T.R.O.; writing—original draft preparation, A.A.P. and T.R.O.; writing—review and editing, A.A.P., M.A.L., L.S., G.V.C., S.D.O., S.D.C., B.D.T., C.A.P., F.L., A.N., A.G.M., A.A.C., O.M.C. and T.R.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Victor Babes University Ethics Committee in Timisoara, Romania (No. 4 from 8 February 2018).

Data Availability Statement

Data are available upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wen, H.; Vuitton, L.; Tuxun, T.; Li, J.; Vuitton, D.A.; Zhang, W.; McManus, D.P. Echinococcosis: Advances in the 21st Century. Clin. Microbiol. Rev. 2019, 32, e00075-18. [Google Scholar] [CrossRef] [PubMed]
  2. Khan, H.; Casulli, A.; Harandi, M.F.; Afzal, M.S.; Saqib, M.A.N.; Ahmed, H. A Retrospective Cohort Study on Human Cystic Echinococcosis in Khyber Pakhtunkhwa Province (Pakistan) Based on 16 Years of Hospital Discharge Records. Pathogens 2022, 11, 194. [Google Scholar] [CrossRef] [PubMed]
  3. Dezsényi, B.; Somorácz, Á.; Danka, J.; Kucsera, I.; Barth, T.F.E.; Casulli, A. Human cystic echinococcosis in Hungary (2000–2014): A retrospective case series analysis from a single-center study. Infection 2018, 46, 477–486. [Google Scholar] [CrossRef] [PubMed]
  4. Eckert, J.; Deplazes, P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin. Microbiol. Rev. 2004, 17, 107–135. [Google Scholar] [CrossRef]
  5. Agudelo Higuita, N.I.; Brunetti, E.; McCloskey, C. Cystic Echinococcosis. J. Clin. Microbiol. 2016, 54, 518–523. [Google Scholar] [CrossRef]
  6. CDC. Available online: https://www.cdc.gov/parasites/echinococcosis/epi.html (accessed on 13 August 2023).
  7. Mandal, S.; Mandal, M.D. Human cystic echinococcosis: Epidemiologic, zoonotic, clinical, diagnostic and therapeutic aspects. Asian Pac. J. Trop. Med. 2012, 5, 253–260. [Google Scholar] [CrossRef]
  8. Matera, G.; Loria, M.T.; Peronace, C.; Catanzariti, T.; Settembre, P.; Giancotti, A.; Lamberti, A.G.; Barreca, G.S.; Galati, L.; Dodaro, G.; et al. Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region. Mediat. Inflamm. 2018, 2018, 4283672. [Google Scholar] [CrossRef]
  9. Mahmoudi, S.; Mamishi, S.; Banar, M.; Babak, B.; Keshavarz, H. Epidemiology of echinococcosis in Iran: A systematic review and meta-analysis. BMC Infect. Dis. 2019, 19, 929. [Google Scholar] [CrossRef]
  10. Nunnari, G.; Pinzone, M.R.; Gruttadauria, S.; Celesia, B.M.; Madeddu, G.; Malaguarnera, G.; Pavone, P.; Cappellani, A.; Cacopardo, B. Hepatic echinococcosis: Clinical and therapeutic aspects. World J. Gastroenterol. 2012, 18, 1448–1458. [Google Scholar] [CrossRef]
  11. Sachar, S.; Goyal, S.; Goyal, S.; Sangwan, S. Uncommon locations and presentations of hydatid cyst. Ann. Med. Health Sci. Res. 2014, 4, 447–452. [Google Scholar] [CrossRef]
  12. Colovic Calovski, I.; Barac, A.; Golubovic, Z.; Karamarkovic, A.; Mitrovic, S.; Milicevic, M.; Cvetkovic, M.; Dzamic, A.M. Case-series study of hepatic echinococcal cysts in Serbia: Viability of scolices, seropositivity and epidemiological characteristics. J. Helminthol. 2018, 92, 161–167. [Google Scholar] [CrossRef] [PubMed]
  13. Eckert, J.; Gemmell, M.A.; Meslin, F.-X.; Pawlowski, Z.S.; World Health Organization. WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern; Eckert, J., Gemmell, M.A., Meslin, F.-X., Pawłowski, Z.S., Eds.; World Organisation for Animal Health: Paris, France, 2001; Available online: https://apps.who.int/iris/handle/10665/42427 (accessed on 13 August 2023).
  14. CDC. Available online: https://www.cdc.gov/parasites/echinococcosis/health_professionals/index.html#tx (accessed on 13 August 2023).
  15. Velasco-Tirado, V.; Romero-Alegría, Á.; Belhassen-García, M.; Alonso-Sardón, M.; Esteban-Velasco, C.; López-Bernús, A.; Carpio-Perez, A.; López, M.F.J.; Bellido, J.L.M.; Muro, A.; et al. Recurrence of cystic echinococcosis in an endemic area: A retrospective study. BMC Infect. Dis. 2017, 17, 455. [Google Scholar] [CrossRef] [PubMed]
  16. WHO Echinococcosis. Available online: https://www.who.int/news-room/fact-sheets/detail/echinococcosis (accessed on 13 August 2023).
  17. Mastrandrea, S.; Stegel, G.; Piseddu, T.; Ledda, S.; Masala, G. A retrospective study on burden of human echinococcosis based on Hospital Discharge Records from 2001 to 2009 in Sardinia, Italy. Acta Trop. 2012, 123, 184–189. [Google Scholar] [CrossRef]
  18. Budke, C.M.; Deplazes, P.; Torgerson, P.R. Global socioeconomic impact of cystic echinococcosis. Emerg. Infect. Dis. 2006, 12, 296–303. [Google Scholar] [CrossRef] [PubMed]
  19. Saadi, A.; Amarir, F.; Filali, H.; Thys, S.; Rhalem, A.; Kirschvink, N.; Raes, M.; Marcotty, T.; Oukessou, M.; Duchateau, L.; et al. The socio-economic burden of cystic echinococcosis in Morocco: A combination of estimation method. PLoS Negl. Trop. Dis. 2020, 14, e0008410. [Google Scholar] [CrossRef]
  20. Youssefi, M.R.; Mirshafiei, S.; Moshfegh, Z.; Soleymani, N.; Rahimi, M.T. Cystic echinococcosis is an occupational disease? J. Parasit. Dis. 2016, 40, 586–590. [Google Scholar] [CrossRef] [PubMed]
  21. Borhani, M.; Fathi, S.; Lahmar, S.; Ahmed, H.; Abdulhameed, M.F.; Harandi, M.F. Cystic echinococcosis in the Eastern Mediterranean region: Neglected and prevailing! PLoS Negl. Trop. Dis. 2020, 14, e0008114. [Google Scholar] [CrossRef]
  22. Lupu, M.A.; Dragomir, A.; Paduraru, A.A.; Ritiu, S.A.; Lazar, F.; Olariu, S.; Valceanu, D.; Botoca, M.R.; Burlacu, O.N.; Cretu, O.M.; et al. Cystic echinococcosis in adult hospitalized patients: A 10-year retrospective study in Western Romania. Int. J. Infect. Dis. 2018, 73S, 299–300. [Google Scholar] [CrossRef]
  23. Mitrea, I.L.; Ionita, M.; Wassermann, M.; Solcan, G.; Romig, T. Cystic echinococcosis in Romania: An epidemiological survey of livestock demonstrates the persistence of hyperendemicity. Foodborne Pathog. Dis. 2012, 9, 980–985. [Google Scholar] [CrossRef]
  24. Deplazes, P.; Rinaldi, L.; Alvarez Rojas, C.A.; Torgerson, P.R.; Harandi, M.F.; Romig, T.; Antolova, D.; Schurer, J.M.; Lahmar, S.; Cringoli, G.; et al. Global Distribution of Alveolar and Cystic Echinococcosis. Adv. Parasitol. 2017, 95, 315–493. [Google Scholar] [CrossRef]
  25. Tamarozzi, F.; Legnardi, M.; Fittipaldo, A.; Drigo, M.; Cassini, R. Epidemiological distribution of Echinococcus granulosus s.l. infection in human and domestic animal hosts in European Mediterranean and Balkan countries: A systematic review. PLoS Negl. Trop. Dis. 2020, 14, e0008519. [Google Scholar] [CrossRef] [PubMed]
  26. Moldovan, R.; Neghina, A.M.; Calma, C.L.; Marincu, I.; Neghina, R. Human cystic echinococcosis in two south-western and central-western Romanian counties: A 7-year epidemiological and clinical overview. Acta Trop. 2012, 121, 26–29. [Google Scholar] [CrossRef] [PubMed]
  27. Neghina, R.; Neghina, A.M.; Marincu, I.; Iacobiciu, I. Epidemiology and epizootology of cystic echinococcosis in Romania 1862–2007. Foodborne Pathog. Dis. 2010, 7, 613–618. [Google Scholar] [CrossRef]
  28. Florea, A.; Coroiu, Z. Epidemiological aspects regarding human hydatidosis in Cluj county in an 18-year period (1991–2008). Sc. Parasit. 2009, 1–2, 63–67. [Google Scholar]
  29. Ministerul Agriculturii şi Dezvoltării Rurale. Available online: https://www.madr.ro/docs/agricultura/strategia-agroalimentara-2020-2030.pdf (accessed on 13 August 2023).
  30. Eurostat. Available online: https://ec.europa.eu/eurostat/databrowser/view/tag00017/default/table?lang=en (accessed on 13 August 2023).
  31. County Directorate of Statistics ARAD. Available online: https://arad.insse.ro/despre-noi/despre-judetul-arad/ (accessed on 13 August 2023).
  32. Timis County Council. Available online: https://www.cjtimis.ro/judetul-timis/prezentarea-judetului/ (accessed on 13 August 2023).
  33. Shahriarirad, R.; Erfani, A.; Ebrahimi, K.; Rastegarian, M.; Eskandarisani, M.; Ziaian, B.; Sarkari, B. Hospital-based retrospective analysis of 224 surgical cases of lung hydatid cyst from southern Iran. J. Cardiothorac. Surg. 2023, 18, 204. [Google Scholar] [CrossRef] [PubMed]
  34. Grosso, G.; Gruttadauria, S.; Biondi, A.; Marventano, S.; Mistretta, A. Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World J. Gastroenterol. 2012, 18, 1425–1437. [Google Scholar] [CrossRef]
  35. Jordanova, D.P.; Harizanov, R.N.; Kaftandjiev, I.T.; Rainova, I.G.; Kantardjiev, T.V. Cystic echinococcosis in Bulgaria 1996–2013, with emphasis on childhood infections. Eur. J. Clin. Microbiol. Infect Dis. 2015, 34, 1423–1428. [Google Scholar] [CrossRef]
  36. Fathi, S.; Ghasemikhah, R.; Mohammadi, R.; Tohidi, F.; Sharbatkhori, M. Seroprevalence of Hydatidosis in People Referring to Reference Laboratory of Gorgan, Golestan Province, Northern Iran 2017. Iran. J. Parasitol. 2019, 14, 436–443. [Google Scholar]
  37. Ursache, A.L.; Györke, A.; Mircean, V.; Matei, I.A.; Cozma, V. Prevalence of Toxocara canis and other endoparasites in client-owned dogs from Cluj county, Romania. Sci. Parasitol. 2017, 17, 101–107. [Google Scholar]
  38. Agriculture and Rural Development. Available online: https://agriculture.ec.europa.eu/system/files/2023-04/csp-at-a-glance-romania_en.pdf (accessed on 10 September 2023).
  39. Bart, J.M.; Morariu, S.; Knapp, J.; Ilie, M.S.; Pitulescu, M.; Anghel, A.; Cosoroaba, I.; Piarroux, R. Genetic typing of Echinococcus granulosus in Romania. Parasitol. Res. 2006, 98, 130–137. [Google Scholar] [CrossRef]
  40. Dărăbuș, G.; Bușe, A.; Oprescu, I.; Morariu, S.; Mederle, N.; Ilie, M.; Imre, M. Investigation on Descriptive Epidemiology, Geographical Distribution, and Genotyping of Echinococcus granulosus s.l. in Bovine from Romania. Vet. Sci. 2022, 9, 685. [Google Scholar] [CrossRef] [PubMed]
  41. Manciulli, T.; Serraino, R.; D’Alessandro, G.L.; Cattaneo, L.; Mariconti, M.; Vola, A.; Taccari, F.; Narra, R.; De Vito, G.; Trecarichi, E.M.; et al. Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. Am. J. Trop. Med. Hyg. 2020, 103, 1951–1954. [Google Scholar] [CrossRef] [PubMed]
  42. Muqaddas, H.; Arshad, M.; Ahmed, H.; Mehmood, N.; Khan, A.; Simsek, S. Retrospective Study of Cystic Echinococcosis (CE) Based on Hospital Record from Five Major Metropolitan Cities of Pakistan. Acta Parasitol. 2019, 64, 866–872. [Google Scholar] [CrossRef] [PubMed]
  43. Tamarozzi, F.; Akhan, O.; Cretu, C.M.; Vutova, K.; Akinci, D.; Chipeva, R.; Ciftci, T.; Constantin, C.M.; Fabiani, M.; Golemanov, B.; et al. Prevalence of abdominal cystic echinococcosis in rural Bulgaria, Romania, and Turkey: A cross-sectional, ultrasound-based, population study from the HERACLES project. Lancet Infect. Dis. 2018, 18, 769–778. [Google Scholar] [CrossRef] [PubMed]
  44. Pierangeli, N.B.; Soriano, S.V.; Roccia, I.; Giménez, J.; Lazzarini, L.E.; Grenóvero, M.S.; Menestrina, C.; Basualdo, J.A. Heterogeneous distribution of human cystic echinococcosis after a long-term control program in Neuquén, Patagonia Argentina. Parasitol. Int. 2007, 56, 149–155. [Google Scholar] [CrossRef]
  45. Possenti, A.; Manzano-Román, R.; Sánchez-Ovejero, C.; Boufana, B.; La Torre, G.; Siles-Lucas, M.; Casulli, A. Potential Risk Factors Associated with Human Cystic Echinococcosis: Systematic Review and Meta-analysis. PLoS Negl. Trop. Dis. 2016, 10, e0005114. [Google Scholar] [CrossRef]
  46. Vlad, D.C.; Neghina, A.M.; Dumitrascu, V.; Marincu, I.; Neghina, R.; Calma, C.L. Cystic echinococcosis in children and adults: A seven-year comparative study in western Romania. Foodborne Pathog. Dis. 2013, 10, 189–195. [Google Scholar] [CrossRef]
  47. Calma, C.L.; Neghina, A.M.; Moldovan, R.; Dumitrascu, V.; Marincu, I.; Neghina, R. Cystic echinococcosis in Arad County, Romania. Vector Borne Zoonotic Dis. 2012, 12, 333–335. [Google Scholar] [CrossRef]
  48. Mustapayeva, A.; Manciulli, T.; Zholdybay, Z.; Juskiewicz, K.; Zhakenova, Z.; Shapiyeva, Z.; Medetov, Z.; Vola, A.; Mariconti, M.; Brunetti, E.; et al. Incidence Rates of Surgically Managed Cystic Echinococcosis in Kazakhstan, 2007–2016. Am. J. Trop. Med. Hyg. 2020, 102, 90–95. [Google Scholar] [CrossRef]
  49. Benecke, J.; Benecke, C.; Ciutan, M.; Dosius, M.; Vladescu, C.; Olsavszky, V. Retrospective analysis and time series forecasting with automated machine learning of ascariasis, enterobiasis and cystic echinococcosis in Romania. PLoS Negl. Trop. Dis. 2021, 15, e0009831. [Google Scholar] [CrossRef]
  50. Petropoulos, A.S.; Chatzoulis, G.A. Echinococcus Granulosus in Childhood: A Retrospective Study of 187 Cases and Newer Data. Clin. Pediatr. 2019, 58, 864–888. [Google Scholar] [CrossRef] [PubMed]
  51. Abdulhameed, M.F.; Habib, I.; Al-Azizz, S.A.; Robertson, I. A retrospective study of human cystic echinococcosis in Basrah province, Iraq. Acta Trop. 2018, 178, 130–133. [Google Scholar] [CrossRef] [PubMed]
  52. Hajipirloo, H.M.; Bozorgomid, A.; Alinia, T.; Tappeh, K.H.; Mahmodlou, R. Human cystic echinococcosis in west azerbaijan, northwest iran: A retrospective hospital based survey from 2000 to 2009. Iran J. Parasitol. 2013, 8, 323–326. [Google Scholar] [PubMed]
  53. Bobić, B.; Nikolić, A.; Radivojević, S.K.; Klun, I.; Djurković-Djaković, O. Echinococcosis in Serbia: An issue for the 21st century? Foodborne Pathog. Dis. 2012, 9, 967–973. [Google Scholar] [CrossRef]
  54. Paduraru, A.A.; Lupu, M.A.; Lighezan, R.; Pavel, R.; Cretu, O.M.; Olariu, T.R. Seroprevalence of Anti-Echinococcus granulosus Antibodies and Risk Factors for Infection in Blood Donors from Western Romania. Life 2023, 13, 871. [Google Scholar] [CrossRef]
  55. Al-Jawabreh, A.; Ereqat, S.; Dumaidi, K.; Nasereddin, A.; Al-Jawabreh, H.; Azmi, K.; Al-Laham, N.; Nairat, M.; Casulli, A.; Maqboul, H.; et al. The clinical burden of human cystic echinococcosis in Palestine, 2010–2015. PLoS Negl. Trop. Dis. 2017, 11, e0005717. [Google Scholar] [CrossRef]
  56. Ernest, E.; Nonga, H.E.; Kynsieri, N.; Cleaveland, S. A retrospective survey of human hydatidosis based on hospital records during the period 1990-2003 in Ngorongoro, Tanzania. Zoonoses Public Health 2010, 57, e124–e129. [Google Scholar] [CrossRef]
  57. Brundu, D.; Piseddu, T.; Stegel, G.; Masu, G.; Ledda, S.; Masala, G. Retrospective study of human cystic echinococcosis in Italy based on the analysis of hospital discharge records between 2001 and 2012. Acta Trop. 2014, 140, 91–96. [Google Scholar] [CrossRef]
  58. Akkucuk, S.; Aydogan, A.; Ugur, M.; Yetim, I.; Davran, R.; Oruc, C.; Kilic, E.; Temiz, M. Comparison of surgical procedures and percutaneous drainage in the treatment of liver hydatide cysts: A retrospective study in an endemic area. Int. J. Clin. Exp. Med. 2014, 7, 2280–2285. [Google Scholar]
  59. van Cauteren, D.; Millo, L.; de Valk, H.; Grenouillet, F. Retrospective study of human cystic echinococcosis over the past decade in France, using a nationwide hospital medical information database. Parasitol. Res. 2016, 115, 4261–4265. [Google Scholar] [CrossRef]
  60. Colombe, S.; Togami, E.; Gelaw, F.; Antillon, M.; Fuentes, R.; Weinberger, D.M. Trends and correlates of cystic echinococcosis in Chile: 2001–2012. PLoS Negl. Trop. Dis. 2017, 11, e0005911. [Google Scholar] [CrossRef] [PubMed]
  61. Bhutani, N.; Kajal, P. Hepatic echinococcosis: A review. Ann. Med. Surg. 2018, 36, 99–105. [Google Scholar] [CrossRef] [PubMed]
  62. Dudha, M.; Shaikh, Z.; Bhaiyat, M.; Wadiwala, I.J.; Bhaiyat, Z.T. A Case of Echinococcal Cyst of the Lung. Respir. Med. Case Rep. 2018, 25, 286–292. [Google Scholar] [CrossRef] [PubMed]
  63. Santivañez, S.J.; Arias, P.; Portocarrero, M.; Rodriguez, S.; Gonzalez, A.E.; Gilman, R.H.; Gavidia, C.M.; Garcia, H.H. Serological Diagnosis of Lung Cystic Hydatid Disease Using the Synthetic p176 Peptide. Clin. Vaccine Immunol. 2012, 19, 944–947. [Google Scholar] [CrossRef]
  64. Acosta-Jamett, G.; Weitzel, T.; Boufana, B.; Adones, C.; Bahamonde, A.; Abarca, K.; Craig, P.S.; Reiter-Owona, I. Prevalence and risk factors for echinococcal infection in a rural area of northern Chile: A household-based cross-sectional study. PLoS Negl. Trop. Dis. 2014, 8, e3090. [Google Scholar] [CrossRef]
  65. Fomda, B.A.; Khan, A.; Thokar, M.A.; Malik, A.A.; Fazili, A.; Dar, R.A.; Sharma, M.; Malla, N. Sero-epidemiological survey of human cystic echinococcosis in Kashmir, North India. PLoS ONE 2015, 10, e0124813. [Google Scholar] [CrossRef]
  66. Sarkari, B.; Hosseini, F.; Abdolahi Khabisi, S.; Sedaghat, F. Seroprevalence of cystic echinococcosis in blood donors in Fars province, southern Iran. Parasite Epidemiol. Control. 2016, 2, 8–12. [Google Scholar] [CrossRef]
  67. Fotiou, V.; Malissiova, E.; Minas, A.; Petinaki, E.; Hadjichristodoulou, C. Seroprevalence of IgG antibodies against Echinococcus granulosus in the population of the region of Thessaly, Central Greece. PLoS ONE 2012, 7, e37112. [Google Scholar] [CrossRef]
  68. Escolà-Vergé, L.; Salvador, F.; Sánchez-Montalvá, A.; Escudero-Fernández, J.M.; Sulleiro, E.; Rando, A.; Bilbao, I.; Lázaro, J.L.; Serres, X.; Salvador, J.; et al. Retrospective Study of Cystic Echinococcosis in a Recent Cohort of a Referral Center for Liver Surgery. J. Gastrointest. Surg. 2019, 23, 1148–1156. [Google Scholar] [CrossRef]
  69. Alexiou, K.; Mitsos, S.; Fotopoulos, A.; Karanikas, I.; Tavernaraki, K.; Konstantinidis, F.; Antonopoulos, P.; Ekonomou, N. Complications of Hydatid Cysts of the Liver: Spiral Computed Tomography Findings. Gastroenterol. Res. 2012, 5, 139–143. [Google Scholar] [CrossRef]
  70. Collado-Aliaga, J.; Romero-Alegría, Á.; Alonso-Sardón, M.; Muro, A.; López-Bernu, A.; Velasco-Tirado, V.; Bellido, J.L.M.; Pardo-Lledias, J.; Belhassen-García, M. Complications Associated with Initial Clinical Presentation of Cystic Echinococcosis: A 20-year Cohort Analysis. Am. J. Trop. Med. Hyg. 2019, 101, 628–635. [Google Scholar] [CrossRef] [PubMed]
  71. Amado-Diago, C.A.; Gutiérrez-Cuadra, M.; Armiñanzas, C.; Arnaíz de Las Revillas, F.; Gómez-Fleitas, M.; Fariñas, M.C. Echinococcosis: A 15-year epidemiological, clinical and outcome overview. Rev. Clin. Esp. 2015, 215, 380–384. [Google Scholar] [CrossRef] [PubMed]
  72. Prousalidis, J.; Kosmidis, C.; Anthimidis, G.; Kapoutzis, K.; Karamanlis, E.; Fachantidis, E. Postoperative recurrence of cystic hydatidosis. Can. J. Surg. 2012, 55, 15–20. [Google Scholar] [CrossRef]
Microorganisms 11 02388 g001
Figure 1. Map of Arad and Timis counties, showing the hospitals where the survey was conducted: (1) County Emergency Clinical Hospital Arad; (2) Municipal Emergency Clinical Hospital Timisoara; (3) “Pius Brînzeu” County Emergency Clinical Hospital Timisoara.
Figure 1. Map of Arad and Timis counties, showing the hospitals where the survey was conducted: (1) County Emergency Clinical Hospital Arad; (2) Municipal Emergency Clinical Hospital Timisoara; (3) “Pius Brînzeu” County Emergency Clinical Hospital Timisoara.
Microorganisms 11 02388 g001
Microorganisms 11 02388 g002
Figure 2. Distribution of CE cases with the corresponding incidences and confidence intervals in adults from Western Romania between 2007 and 2022. R2—goodness-of-fit measure for the linear regression equation; I—incidence; CI—95% confidence interval.
Figure 2. Distribution of CE cases with the corresponding incidences and confidence intervals in adults from Western Romania between 2007 and 2022. R2—goodness-of-fit measure for the linear regression equation; I—incidence; CI—95% confidence interval.
Microorganisms 11 02388 g002
Table 1. Distribution of CE cases in Western Romania according to age groups and gender (n = 366).
Table 1. Distribution of CE cases in Western Romania according to age groups and gender (n = 366).
VariableGenderTotal (%)
Male (%)Female (%)
18–2930 (42.9)40 (57.1)70 (19.1)
30–3931 (51.7)29 (48.3)60 (16.4)
40–4937 (51.4)35 (48.6)72 (19.7)
50–5937 (44.6)46 (55.4)83 (22.7)
≥6037 (45.7)44 (54.3)81 (22.1)
Total172 (47)194 (53)366 (100)
Table 2. Distribution of CE cases in Western Romania according to gender and area of residence (n = 366).
Table 2. Distribution of CE cases in Western Romania according to gender and area of residence (n = 366).
VariableArea of ResidenceTotal (%)
Rural (%)Urban (%)
Gender
Female116 (59.8)78 (40.2)194 (53)
Male109 (63.4)63 (36.6)172 (47)
Total (%)225 (61.5)141 (38.5)366 (100)
Table 3. Distribution of cystic echinococcosis cases by anatomical localization of the cysts.
Table 3. Distribution of cystic echinococcosis cases by anatomical localization of the cysts.
Localization of the CystNo. of Cases n = 366 (%)
Liver302 (82.5)
Lungs48 (13.1)
Spleen6 (1.6)
Kidneys4 (1.1)
Other *6 (1.6)
Multiple organ involvementNo. of cases n = 23 (%)
Liver associated with:
Lung6 (26.1)
Peritoneum6 (26.1)
Spleen2 (8.7)
Pelvis2 (8.7)
Iliopsoas muscle1 (4.3)
Gallbladder1 (4.3)
Kidney1 (4.3)
Kidney and spleen1 (4.3)
Lung and spleen1 (4.3)
Lung associated with heart1 (4.3)
Spleen associated with retroperitoneum1 (4.3)
* Other: peritoneum (3 cases), retroperitoneum (1 case), muscle (1 case), and bone (1 case).
Table 4. Distribution of CE cases according to treatment instituted (n = 366).
Table 4. Distribution of CE cases according to treatment instituted (n = 366).
VariableNo. of Cases (%)
Treatment
Surgery298 (81.4)
PAIR53 (14.5)
Only chemotherapy8 (2.2)
Watch and wait7 (1.9)
Adjuvant therapy
Albendazole99 (27)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Paduraru, A.A.; Lupu, M.A.; Sima, L.; Cozma, G.V.; Olariu, S.D.; Chiriac, S.D.; Totolici, B.D.; Pirvu, C.A.; Lazar, F.; Nesiu, A.; et al. Cystic Echinococcosis in Hospitalized Adult Patients from Western Romania: 2007–2022. Microorganisms 2023, 11, 2388. https://doi.org/10.3390/microorganisms11102388

AMA Style

Paduraru AA, Lupu MA, Sima L, Cozma GV, Olariu SD, Chiriac SD, Totolici BD, Pirvu CA, Lazar F, Nesiu A, et al. Cystic Echinococcosis in Hospitalized Adult Patients from Western Romania: 2007–2022. Microorganisms. 2023; 11(10):2388. https://doi.org/10.3390/microorganisms11102388

Chicago/Turabian Style

Paduraru, Ana Alexandra, Maria Alina Lupu, Laurentiu Sima, Gabriel Veniamin Cozma, Sorin Dan Olariu, Sorin Dan Chiriac, Bogdan Dan Totolici, Catalin Alexandru Pirvu, Fulger Lazar, Alexandru Nesiu, and et al. 2023. "Cystic Echinococcosis in Hospitalized Adult Patients from Western Romania: 2007–2022" Microorganisms 11, no. 10: 2388. https://doi.org/10.3390/microorganisms11102388

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop